Efficacy and safety of anti-TNF therapies in psoriatic arthritis: an observational study from the British Society for Rheumatology Biologics Register

@inproceedings{Saad2017EfficacyAS,
  title={Efficacy and safety of anti-TNF therapies in psoriatic arthritis: an observational study from the British Society for Rheumatology Biologics Register},
  author={Amr Ahmed Saad and Darren M Ashcroft and Kath D. Watson and Deborah P. M. Symmons and Peter R. Noyce and Kimme L Hyrich},
  booktitle={Rheumatology},
  year={2017}
}
Recently we reviewed our own manuscript entitled ‘‘Efficacy and safety of anti-TNF therapies in psoriatic arthritis: an observational study from the British Society for Rheumatology Biologics Register’’, originally published in Rheumatology in January 2010, and have identified an error in the calculation of incident rates and incident rate ratios presented in Table 5. We were able to retrieve the dataset and original statistical files used to generate these results and have identified a… CONTINUE READING
Tweets
This paper has been referenced on Twitter 14 times. VIEW TWEETS

References

Publications referenced by this paper.
SHOWING 1-10 OF 25 REFERENCES

Improvements in quality of life and functional status in patients with psoriatic arthritis receiving anti-TNF therapies: data from the BSR Biologics Register (BSRBR)

  • AA Saad, DM Ashcroft, KD Watson, DP Symmons, PR Noyce, KL. Hyrich
  • Pharmacoepidemiol Drug Saf
  • 2009

Rheum Dis 2008;67:855–9

  • arthritis. Ann
  • 2008

The comparative effectiveness of anti-TNF therapy and methotrexate in patients with psoriatic arthritis: 6 month results from a longitudinal, observational, multicentre study

  • MS Heiberg, C Kaufmann, E Rodevand
  • Ann Rheum Dis ;66:1038–42
  • 2007

NICE technology appraisal guidance 104 – etanercept and infliximab for the treatment of adults with psoriatic arthritis

  • ML Prevoo, MA van’tHof, HH Kuper, MA vanLeeuwen, LB vandePutte, PL vanRiel
  • 2006

Similar Papers

Loading similar papers…